PPT-Supplemental Figure 1 Supplemental Figure 2

A B Supplemental Figure 3 Control αsynuclein Vehicle Nicotine A B C D No RNAi SV2L1 KD SV2L2 KD. A. Academic/Research Program. Extent of Lung Resection. No. of Subject. Event. Censored. Median Survival (95% CI). 60 mo Survival. Lobectomy. 1778. 616 (35%). 1162 (65%). NA (99.6, NA). 73.6% (71.4%, 75.6%). TAM (1µM). 72 hours. IL-1β levels. 48 hours. LPS (1µM). 0. A. NLRP3i (400μM. ). B. Supplemental Figure 4. Effect of the NLRP3 inflammasome inhibitor on IL‑1β production in bone marrow derived macrophages (BMDM) from genetically modified mice with constitutively active NLRP3.. Data source: . Wang R, Pan Y, Li C, et al. Analysis of major known driver mutations and prognosis in resected . adenosquamous. lung carcinomas. J . Thorac. . Oncol. . 2014;9:760-8. . Kohno T, . Nakaoku. AS9104/2A. &. Special Audit Discussion. Tim Lee. The Boeing Company. Chair, IAQG OPMT. 23 July 2015. Purpose. To provide awareness and understanding of the AS9104/2A criteria for AAQG Member supplemental Certification Body (CB) oversight.. Payments for Services Provided in Managed . Care. 1. 2. INTRODUCTION TO Medicaid managed care – THE 3 players . FOR SUPPLEMENTAL PAYMENT PURPOSES. The State - enters into a contract with the managed care entity to arrange for the delivery of Medicaid managed care services. Figure . S1. . . (A) . Schematic shows the three KREN1, KREN2, and KREN3 ~20S editosomes, and their protein interactions identified by yeast two-hybrid and co-expression studies (dashed lines) (Schnaufer et al. 2003; Schnaufer et al. 2010; Mehta et al. 2015). (B-D) Networks show detailed editosome architecture revealed by cross-linking and mass spectrometry (CXMS) (McDermott et al. 2016). Network edge widths are proportional to the number of interlinks observed between two proteins. All previously described interactions between editosome proteins were found in our cross-linking data. . CD44. GM130. CD40. MSCs. EVs. B. C. Supplemental Figure 1. Supplemental Figure 2. Supplemental Figure 3 . Supplemental Figure 4. A. B. A. B. C. Supplemental Figure 5. D. SSC. CD206. CD206. 25.7%. 14%. 1. 5. 10. 30. 50. 100. SP600125. 0,1. 1. 2. 5. 10. 20. ER-27319. 1. 5. 10. 30. 50. 100. Inhibitors concentration (µM). A. B. Supplemental Figure 1: B cell survival (A) . B cells were pre-treated with kinase inhibitors (GF109203 (PKC. bilateral and diffuse distribution of cysts, with moderate or severe replacement of kidney tissue by cysts, where all cysts contribute similarly to total kidney volume. 55-60 year-old female:. PKD1_Gly2034Val. 3. Table 1. . Significance level of comparison of absolute sweat rates for all regions measured at exercise intensity 1, uncorrected for multiple comparisons. . Supplemental Digital Content . 3. Table . suboptimally. positioned. There was a normal . cardiothymic. silhouette. The lungs were clear. Air in scattered loops of . nondilated. small and large bowel, within all four quadrants of the abdomen.. B. Supplemental Figure 2. Tissue. Adrenal gland . Appendix. Appendix . Bone marrow . Breast . Breast cancer. Bronchus Respiratory . Cartilage. Cerebellum . Cerebellum . Cerebellum . Cerebral cortex. Cerebral cortex. children . aged 2–5 years . in Medicaid receiving . clinical care for . attention-deficit/hyperactivity disorder (ADHD): United States, 2011. 0.45-1.40%. 1.41-1.70%. 1.71-2.05%. 2.06-3.38%. SUPPLEMENTAL FIGURE 5. . Top layer. Bottom layer. PDMS rod. +. cells. Nuclei. F-actin. Supplemental Figure 1: Lung Endothelial MPS. A.. B.. Supplemental Figure 1: A) Schematic of lung endothelial MPS. B) Imaging demonstrating coverage with endothelial cells prior to incubation of plasma in the lumens..